Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
NCT00030459 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-08-07
Summary
RATIONALE: Palliative therapy may help patients with advanced cancer live more comfortably. It is not yet known if palliative therapy is more effective with or without chemotherapy in treating patients who have malignant mesothelioma.
PURPOSE: Randomized phase II trial to compare the effectiveness of palliative therapy with or without different chemotherapy regimens in treating patients who have malignant mesothelioma.
Conditions
- Malignant Mesothelioma
Interventions
- DRUG
- DRUG
-
mitomycin C
- DRUG
-
vinblastine sulfate
- DRUG
-
vinorelbine tartrate
Sponsors & Collaborators
- collaborator OTHER_GOV
-
British Thoracic Society
lead OTHER
Principal Investigators
-
Martin F. Muers, MD · Leeds General Infirmary
-
David J. Girling, MD · Medical Research Council
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-11-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003346 ·Status: COMPLETED ·Phase: PHASE2
-
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
NCT04177953 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
NCT02613312 ·Status: TERMINATED
-
Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
NCT00003747 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiation and Combination Immunotherapy for Melanoma
NCT03850691 ·Status: COMPLETED ·Phase: PHASE2
-
Mesothelioma and Radical Surgery 2
NCT02040272 ·Status: UNKNOWN ·Phase: NA
-
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
NCT00054002 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
NCT00110123 ·Status: TERMINATED ·Phase: PHASE3
-
Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma
NCT02639767 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fotemustine in Treating Patients With Metastatic Melanoma
NCT00560118 ·Status: TERMINATED ·Phase: PHASE2
-
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
NCT00003263 ·Status: COMPLETED ·Phase: PHASE1
-
Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma
NCT00072124 ·Status: COMPLETED ·Phase: PHASE3
-
CP-461 in the Treatment of Patients With Advanced Melanoma
NCT00060710 ·Status: TERMINATED ·Phase: PHASE2
-
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
NCT05278975 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
NCT00003027 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
NCT00264056 ·Status: UNKNOWN ·Phase: NA
-
Dasatinib in Resectable Malignant Pleural Mesothelioma
NCT00652574 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
NCT01666418 ·Status: COMPLETED ·Phase: PHASE2
-
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
NCT02497053 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
NCT00314106 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
NCT00004141 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
NCT02816021 ·Status: COMPLETED ·Phase: PHASE2
-
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
NCT04166734 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma
NCT03422445 ·Status: UNKNOWN ·Phase: PHASE2
-
Intralesional PV-10 Chemoablation of Metastatic Melanoma
NCT00219843 ·Status: COMPLETED ·Phase: PHASE1